I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Subclassification of the diagnosis of several types of tumors, including breast cancers, brain tumors, adrenal cortical carcinomas, thyroid cancers, and neuroendocrine neoplasms, has been based on the quantitation of proliferation.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] The classification and risk stratification of these diagnostic entities include mitotic counts and the assessment of a Ki67 labeling index.\[[@ref9]\] Ki67 was initially identified as an antigen associated with mitosis in mammalian cells by investigators in Kiel (hence the Ki in the name).\[[@ref10]\] The use of this biomarker has become the subject of intense controversy.\[[@ref6]\] The labeling index of this antigen has been counted by eyeballing slides, by manual counts of printed images photographed at the microscope, and by automated image analysis algorithms. Because the reproducibility of Ki67 positive cell counts is poor, particularly when eyeballing\[[@ref7][@ref11][@ref12][@ref13]\] careful manual counts of printed images or automated image analysis have been recommended to improve the accuracy of this biomarker.\[[@ref12][@ref13][@ref14]\] In addition, staining results are subjected to interlaboratory variation that is dependent on both tissue fixation and staining technology.\[[@ref8][@ref15]\]

In an effort to ensure accurate and reproducible Ki67 labeling indices, we implemented an image analysis tool in the Department of Pathology at the University Health Network, Toronto. The validation was undertaken by the endocrine pathologists who assess a large number of cases, for which the Ki67 labeling index is used to grade neuroendocrine neoplasms.\[[@ref3][@ref14]\] During the course of validation, we compared this tool to the previous method of calculating the Ki67 labeling index, manual counts of printed images of the region of interest (ROI). We report here the results of this validation in terms of accuracy, time, and reproducibility. More importantly, during this validation, it became apparent that different types of specimens, specifically biopsies or resections, alter the availability of tissue for analysis, and some biopsies did not yield the recommended number of cells; the availability of this tool allowed comparisons of different ROIs based on the number of cells and number of regions selected for analysis.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Materials {#sec2-1}
---------

According to guidelines,\[[@ref16]\] following primary use-case validation of digital pathology using at least 60 cases, each additional use-case validation requires 20 additional cases. For this study, we collected 20 consecutive cases of neuroendocrine neoplasms; these tumors had Ki67 labeling indices reflective of the wide range of these tumors, from very low (approximately 0.1%) to high (approximately 75%). These included primary neuroendocrine tumors of stomach, small bowel, appendix, pancreas, lung and ovary, liver metastases from lung and small bowel neuroendocrine tumors, and paraganglioma. Sections of 5-μm thickness were stained on the Roche Ventana Benchmark using the MIB1 antibody (Dako, Santa Clara, CA, USA). Slides were scanned with a Leica Aperio AT2 Scanner (Leica Biosystems, Vista, CA, USA) and accessed through the CoPathPlus laboratory information system (Cerner, Kansas City, MO, USA) interfaced with Aperio eSlideManager through Aperio ImageScope (Leica Biosystems) as previously described.\[[@ref17]\] The pretuned nuclear algorithm (Leica Biosystems) was used for automated analysis of slides stained for Ki67.

Validation of image analysis algorithm {#sec2-2}
--------------------------------------

Since the program used does not have the ability to identify the regions of highest labeling, also known as "hotspots," we identified ROIs on the digital slides by visually selecting the area of highest labeling. We outlined the ROI using a frame and then annotated the area within the frame using the ImageScope software to manually outline stroma for exclusion in the ImageScope analysis \[[Figure 1](#F1){ref-type="fig"}\]. The selected and annotated regions were photographed, printed, and distributed to four pathologists (OM, SP, DAG, and SLA) who performed manual counts as per their usual practice following the WHO recommendation that "manual counting using printed images is advocated."\[[@ref14]\] The outlined ROIs in the whole slide image were subjected to image analysis using the image analysis nuclear algorithm for determination of the Ki67 labeling index on three occasions. Each analysis was timed from the onset of analysis to completion. This timing did not include the time required for ROI selection and annotation, as the annotations were made in advance and then the ROI was printed ×4 for manual counting by each individual who was blinded to the results of the other users and the image analysis algorithm.

![Sample photographs of annotated figures used for Ki67 quantitation by manual counts and automated image analysis. These images illustrate examples of how annotations were applied for quantitation of Ki67 labeling index for validation of an automated algorithm. Sample slides were annotated with a square to identify the region of interest, then annotations were made to exclude the stroma. The resulting images were printed for manual counting and subjected to the automated algorithm for analysis](JPI-10-8-g001){#F1}

The results of the analyses by each of the four pathologists and the algorithm were compiled \[[Table 1](#T1){ref-type="table"}\] and compared \[[Figure 2](#F2){ref-type="fig"}\].

###### 

Comparisons of results of Ki67 in 20 cases

  Cases     Nuclear algorithm   Observer 1   Observer 2   Observer 3   Observer 4                                                          
  --------- ------------------- ------------ ------------ ------------ ------------ ------- ------ ---- ------- ------ ---- ------- ------ ----------------------------------------------------------------------------------------------------
  Case 1    2.119               1463         1.84         1412         10           1.57    1400   30   1.99    951    9    1.76    1303   Time was not recorded for individual cases. Estimated time was between 15 and 30 min for each case
  Case 2    0.107               931          0.12         853          8            0.17    574    13   0.16    618    7    0.12    799    
  Case 3    3.425               1664         3.84         1951         20           2.26    1944   50   6.53    826    10   2.91    1747   
  Case 4    4.145               3643         5.46         2380         22           3.85    2392   48   7.08    1581   20   4.49    2334   
  Case 5    6.586               911          6.98         1147         23           5.44    1047   15   12.15   576    9    3.18    2008   
  Case 6    1.606               2366         2.09         956          23           1.67    836    16   2.98    569    8    1.92    727    
  Case 7    1.497               1670         1.25         1600         22           1.44    1320   23   2.13    935    7    1.54    1422   
  Case 8    3.091               2556         3.89         2186         32           2.56    2104   45   7.68    924    15   3.75    1810   
  Case 9    2.870               1289         3.06         1177         25           2.32    1290   20   4.06    689    10   3.11    1123   
  Case 10   9.287               1346         11.31        1494         18           7.36    1522   40   13.23   922    13   9.66    1314   
  Case 11   2.027               1529         1.92         3122         28           1.16    2681   55   2.27    1540   21   1.58    2423   
  Case 12   5.849               1915         7.47         2125         22           4.88    1945   30   13.22   809    13   7.61    1510   
  Case 13   29.651              1059         31.02        1054         25           27.31   908    18   38.12   758    14   32.4    876    
  Case 14   1.971               558          2.11         427          9            2.76    326    6    2.76    289    3    2.44    368    
  Case 15   47.259              821          48.85        782          18           36.11   720    15   56.35   456    9    45.92   699    
  Case 16   5.151               1553         5.77         1525         20           3.97    1510   28   8.71    769    11   5.43    1269   
  Case 17   10.779              1375         9.55         1476         27           7.47    1405   22   15.29   817    11   9.35    1283   
  Case 18   1.692               2601         1.63         1778         25           1.32    1216   25   3.61    831    11   1.9     1315   
  Case 19   19.350              571          15.29        713          12           10.41   826    13   22.52   444    10   14.48   773    
  Case 20   73.374              661          81.24        485          10           62.30   573    13   86.64   614    9    81.74   586    

![Results of manual and automated counts of Ki67 labeling index. (a) Includes the entire scale from 0% to 100%. (b) Is an expanded view of the cases close to the 20% cutoff for G2 versus G3 neuroendocrine tumors. (c) Is expanded to show the variability at the previous 2% and revised 3% cutoff to separate G1 from G2 neuroendocrine tumors](JPI-10-8-g002){#F2}

Reproducibility of the algorithm based on user determinations {#sec2-3}
-------------------------------------------------------------

Since some of the specimens were resection specimens with large tissue pieces, while others were biopsies with fewer cells, and some of the biopsies were intact cores, while others were multiple small fragments, we recognized that the selection of a "hot spot" varied from specimen to specimen. In resection specimens, the initial approach was to identify the single area of highest labeling and identify an area that had at least 1000 cells; in some cases, more than 1000 cells were counted. In some biopsies, it was difficult to obtain 1000 cells, and in fragmented biopsies, to achieve a total cell count of more than 500 cells, it was frequently necessary to identify multiple small "hotspots."

To determine the impact of selection of the ROI on the outcome and classification of the tumor, we performed the analysis using multiple approaches. We carried out the automated analyses on a single tumor using different numbers of total cells and multiple small versus single large areas of hot spots.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Validation of image analysis algorithm {#sec2-4}
--------------------------------------

The results obtained using the automated image analysis algorithm compared with manual counts of the same annotated areas by multiple observers are shown in [Table 1](#T1){ref-type="table"} and illustrated in [Figure 2](#F2){ref-type="fig"}.

Analysis of annotated areas by the algorithm resulted in identical results when repeated multiple times. Overall, the automated analysis correlated with the pathologists' results in the majority of cases. However, the manual counts varied from pathologist to pathologist \[[Figure 2](#F2){ref-type="fig"}\] depending on the interpretation of the selected area. Specifically, there were two areas of difference.First, while the algorithm identifies any staining as positive, there was discordance among pathologists regarding inclusion of very weak signals. Second, some pathologists counted all nuclei, while others omitted nuclei within the analysis area that could possibly be interpreted as stroma. These differences are known to contribute to interobserver variability in tumor grading.

Time savings by image analysis {#sec2-5}
------------------------------

The automated algorithm provided results within few seconds compared to up to 55 min per analysis when performed manually \[[Table 1](#T1){ref-type="table"}\]. This timing did not include the time required for annotation of the initial image; it only included the time for actual counting on printed images.

Reproducibility of the algorithm based on user determinations {#sec2-6}
-------------------------------------------------------------

We repeated the analysis of a given tumor using larger or smaller frames to include more or fewer cells in the same region that had been identified as the "hotspot." We identified a consistent variation of the Ki67 labeling index based on cell number; the more cells counted, the lower the Ki67 value obtained, with the highest variation at the low end of the spectrum \[[Figure 3](#F3){ref-type="fig"}\]. This impacted the cutoff points that have been defined for the distinction of Grade 1 from Grade 2 neuroendocrine tumors\[[@ref3][@ref14]\] such that counting 1000 cells could result in a tumor being classified as moderate grade (G2), whereas counting 2000 cells or more resulted in the same tumor being classified as low grade (G1). The same occurred for tumors close to the 20% cutoff for intermediate- versus high-grade (G3) classification.

![Results of automated counts using different numbers of cells. In the example shown in (a), counting a field that included 1906 cells provided a Ki67 labeling index of 2.99%; in contrast, counting 1455 cells in the same area using a smaller region of interest resulted in a Ki67 labeling index of 3.09% for this tumor. Using the current WHO classification, the difference makes this either a G1 or a G2 tumor. In (b), counting 1421 cells provide a Ki67 of 19.49% and classification as a G2 tumor, whereas counting 992 cells results in a Ki67 of 21.27% and classification as a G3 tumor](JPI-10-8-g003){#F3}

Since biopsies can be fragmented and yield multiple small pieces of tissue for analysis, we then examined the impact of selecting multiple small regions compared to a single large region to obtain the required number of cells \[[Figure 4](#F4){ref-type="fig"}\]. It was evident that selection of multiple regions of intense labeling resulted in a higher value than selection of a single region of the same number of cells even if overall that represented the most intense hot spot.

![Results of automated counts using multiple regions of interest versus a single region of interest. The figures on the left show the annotation of a large area, whereas those on the right show multiple small areas selected for analysis. These different approaches to annotation of the small biopsy in (a) yielded a Ki67 labeling index of 13.2829% in 1453 cells (left) versus 21.825% in 996 cells (right). In the larger sample shown in (b), the results were 2.185% in 1144 cells (left) versus 7.285% in 1057 cells (right)](JPI-10-8-g004){#F4}

C[ONCLUSIONS]{.smallcaps} {#sec1-4}
=========================

This study was performed as part of the validation of new technology in the laboratory. Our results confirm that there is a significant benefit of automated image analysis as part of daily pathologists' workflow, both in the consistency of the automated results and in the time savings for pathologists. Our study did not include the time required to identify hotspots or to annotate images for counting, we assume that the time required for such annotation would not be significantly different using printed images or the ROI on a computer screen since the work to do this is mainly a factor of pathologist recognition and labeling of stromal elements for exclusion. As new algorithms are developed that can recognize hot spots and perform automated segmentation to exclude stromal elements, the time required for these activities will be reduced.

The ability to perform fast and reliable image analysis for quantification of morphologic features allowed us the opportunity to pursue a more in-depth analysis of the impact of tissue annotation for the analysis of the Ki67 labeling index.

We have identified significant interobserver variation due to pathologist interpretation. Despite the instructions to use the prepared annotations, one pathologist had consistently higher Ki67 results when using manual counts of printed images. This was attributed to the fact that this pathologist excluded any cell that was perceived as stroma or blood vessel even if it was included in the countable region of the ROI. Therefore, the results would have differed whether using manual counts or automated image analysis. Some differences may possibly be related to the inclusion of very weak signals by some and not all observers, the algorithm is set to include even weak and/or focal staining as positive.

This study analyzed hotspots that were identified by a pathologist. As image analysis tools become more sophisticated, automated tumor/stroma segmentation will become a common standard. However, the insights that we obtained in our study will need to be considered when developing those segmentation algorithms, to establish how to identify a hotspot based on the total number of cells available or required, whether a single area only should be analyzed, and if so, how such an algorithm can be applied to small biopsies.

While variation in Ki67 labeling results has been attributed to the known heterogeneity of different areas within neuroendocrine tumors,\[[@ref18]\] we have also confirmed significant variation of the Ki67 labeling index based on the size and number of ROIs. Our data confirmed the obvious result that counting more cells skews the result for cases with relatively low Ki67 labeling. The same is true when selecting multiple very small areas compared with a large tissue region, even when the total number of cells is the same. This concentration effect has a significant impact when considering that much of current practice rests on results obtained from small biopsies that frequently have either too few cells for a complete analysis or may be fragmented, yielding multiple small regions. The ability to push a tumor from a G1 to G2 or G2 to G3 classification can be as simple as reducing the number of cells counted from 1500 to 1000 or selecting multiple small hot spots rather than a single larger area of the same tumor. The literature has not dealt with this issue rigorously; the WHO has recommended that "the Ki67 proliferation index is based on the evaluation of equal and \>500 cells in areas of higher nuclear labeling (so-called hotspots)."\[[@ref14]\] The implication of this is that more is better, and some pathologists try to count as many cells as possible; with automated tools, it is easier to count more cells or even the entire slide, yet our data show that this alters the result in a way that can be significant to grading of a neuroendocrine tumor. Careful studies based on rigorous and consistent protocols are needed to prevent concentration or dilution effects and to determine the correct mechanism for counting that is clinically relevant. The application of this analysis in biopsies complicates the matter since often biopsies do not contain sufficient numbers of cells to achieve recommended counts. While some would argue that results close to a cutoff should be rounded up to the nearest whole integer,\[[@ref14]\] there are no guidelines on this issue. There is a need for a rigorous study using image analysis tools and standardized numbers of cells to determine the diagnostic cutoffs that are clinically significant or to update the approach to this continuous variable. Indeed, it may be that the Ki67 labeling index should not have set cutoffs that can be manipulated as showed in this study. The impact of this on grading of neuroendocrine tumors and other tumor types will be significant.

In conclusion, we report that the application of automated image analysis for the enumeration of a Ki67 labeling index provides a fast and accurate tool for this methodology. However, we provide examples of variations that result from the size and number of selected fields to determine the ROI for analysis. These results highlight the importance of developing a standardized approach to quantitation in anatomical pathology and raise concerns about the rigid cutoffs for tumor grading that have been promoted based on nonstandard studies.
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